Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. DEF 14A Proxy Proxy Statement
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. DEF 14A Proxy Proxy Statement
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement
  14. DEF 14A Proxy Proxy Statement
  15. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 15 filings